Menu
GeneBe

NPAS3

neuronal PAS domain protein 3, the group of PAS domain containing|Basic helix-loop-helix proteins

Basic information

Region (hg38): 14:32934395-33820863

Links

ENSG00000151322NCBI:64067OMIM:609430HGNC:19311Uniprot:Q8IXF0AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the NPAS3 gene.

  • Inborn genetic diseases (35 variants)
  • not provided (17 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the NPAS3 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
6
clinvar
5
clinvar
11
missense
35
clinvar
2
clinvar
1
clinvar
38
nonsense
1
clinvar
1
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
1
clinvar
1
clinvar
2
Total 0 0 36 9 7

Variants in NPAS3

This is a list of pathogenic ClinVar variants found in the NPAS3 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
14-33215174-G-A Likely benign (Oct 10, 2018)713996
14-33215287-A-C Likely benign (Aug 01, 2023)2644157
14-33215335-T-C Benign (Nov 16, 2018)786617
14-33215391-G-A not specified Uncertain significance (Jun 03, 2022)2369784
14-33676202-G-A Benign (Sep 24, 2018)721504
14-33676268-A-C not specified Uncertain significance (Apr 04, 2023)2524295
14-33676298-C-A not specified Uncertain significance (Jan 23, 2023)2467560
14-33676349-G-A not specified Uncertain significance (Sep 14, 2023)2624222
14-33774351-A-G Likely benign (Aug 09, 2018)763481
14-33774364-C-G not specified Uncertain significance (May 08, 2023)2514682
14-33774373-T-G not specified Uncertain significance (Dec 21, 2023)3201537
14-33774418-G-A not specified Uncertain significance (Sep 15, 2021)2249457
14-33774490-C-T Uncertain significance (Nov 01, 2022)2644158
14-33774509-A-G not specified Uncertain significance (Apr 04, 2023)2515902
14-33778542-G-C not specified Uncertain significance (Nov 17, 2022)2398939
14-33797523-C-T Benign (Dec 31, 2019)771468
14-33797565-C-A not specified Uncertain significance (Feb 27, 2024)3201525
14-33799745-A-G not specified Uncertain significance (Apr 12, 2022)2282859
14-33799775-T-A not specified Uncertain significance (Jun 30, 2022)2299436
14-33799786-C-T Benign (Jul 31, 2018)784281
14-33799807-G-C Likely benign (Nov 01, 2022)2644159
14-33799812-A-C not specified Uncertain significance (Mar 01, 2023)2465543
14-33799838-A-G not specified Uncertain significance (Feb 05, 2024)3201526
14-33799877-G-A Uncertain significance (Feb 12, 2022)2097122
14-33799946-T-C not specified Uncertain significance (Dec 28, 2023)2390467

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
NPAS3protein_codingprotein_codingENST00000356141 12869244
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.000.0002631257250231257480.0000915
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense3.143645760.6320.00003646016
Missense in Polyphen107176.120.607551802
Synonymous0.4452512600.9650.00001991873
Loss of Function5.16336.80.08150.00000204405

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.00004620.0000462
European (Non-Finnish)0.0001940.000193
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: May play a broad role in neurogenesis. May control regulatory pathways relevant to schizophrenia and to psychotic illness (By similarity). {ECO:0000250}.;

Recessive Scores

pRec
0.146

Intolerance Scores

loftool
0.347
rvis_EVS
-1.35
rvis_percentile_EVS
4.6

Haploinsufficiency Scores

pHI
0.301
hipred
Y
hipred_score
0.752
ghis
0.615

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.231

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Npas3
Phenotype
respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); immune system phenotype; growth/size/body region phenotype; homeostasis/metabolism phenotype;

Gene ontology

Biological process
regulation of transcription by RNA polymerase II;positive regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II
Cellular component
nucleus;nucleoplasm;cytosol
Molecular function
DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;protein heterodimerization activity